- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
- Website
- Location
- Company size
- 1-10 people
- Total raised
- $3.5M
- Markets
HepaTx careers
Hepatx is developing cellular therapies to address the need for treatments for patients with life-threatening liver disease. Hepatx uses proprietary technology from Stanford University to manufacture induced hepatocytes (liver cells) to replace those lost to disease through a simple infusion.
HepaTx hasn't added any jobs yet
Get notified when HepaTx posts new jobs.
Mark Chao
Eric Schuur
Early employee @Calydon, founder @GeneSource, Inc., Dir. ClinicalScientific Affairs @Asthmatx, Genomic Health, Inc., founder @VMWA LLC, founder @HepaTx
Valuation
$10M
Funded over
1 round
Latest round
Seed (Jul 2018)
Quartzy • Houston • 3 weeks ago
Penumbra • Berlin • 3 weeks ago
Vidyard • Canada • 3 weeks ago
Houzz • Nepal • 4 weeks ago
Pinterest • Toronto • 1 month ago